What is the appropriate hydrocortisone dosing regimen for pediatric patients in shock suspected to be due to adrenal insufficiency or refractory septic shock?

Hydrocortisone Dosing in Pediatric Shock

For pediatric patients with adrenal crisis or catecholamine-resistant septic shock, administer hydrocortisone 2 mg/kg every 6 hours (or 8 mg/kg/day total) via IV, IM, or SC routes. 1

Clinical Context and Indications

Hydrocortisone is indicated in two distinct pediatric shock scenarios:

1. Absolute Adrenal Insufficiency with Shock

• Definition: Peak cortisol <18 μg/dL after ACTH stimulation 2
• High-risk populations:
  • Purpura fulminans/Waterhouse-Friderichsen syndrome
  • Prior chronic steroid therapy
  • Pituitary/adrenal abnormalities
  • Meningococcemia (markedly depressed aldosterone levels) 2

2. Catecholamine-Resistant Septic Shock

• Timing: After adequate fluid resuscitation (up to 60 mL/kg) and vasopressor initiation fail to restore hemodynamic stability 3
• Grade 1A recommendation for timely hydrocortisone therapy in fluid-refractory, catecholamine-resistant shock with suspected/proven absolute adrenal insufficiency 3

Dosing Regimen

Acute Crisis/Shock Dosing

Hydrocortisone hemisuccinate 2 mg/kg every 6-8 hours 1

Administration routes (in order of preference based on access):

• IV drip every 6 hours
• IM injection every 6-8 hours
• SC injection every 6-8 hours 1

Alternative dosing range: The 2009 ACCM guidelines note a broader range of 2-50 mg/kg/day can be titrated to resolution of shock, though the French consensus strongly recommends the 2 mg/kg every 6 hours approach 2

Duration and Weaning

• Continue until hemodynamic stability achieved or maximum 7 days 3
• After stabilization, transition to oral hydrocortisone at triple the normal maintenance dose (typically ≥60 mg/day in adults, proportionally adjusted for children) 1
• Split into three daily doses (morning, midday, evening)
• Gradually taper over several days to normal replacement dose
• Wean as tolerated to minimize long-term toxicities 2

Critical Supportive Management

Fluid and Electrolyte Correction

Parenteral rehydration is essential 1:

• 5% or 10% glucose for hypoglycemia
• NaCl provision: 10-15 mEq/kg/day (maximum 408 mEq/day)
• Fluid volumes by age:
  • Newborns: 150-180 mL/kg/day
  • Children: 2.5-3 L/m²/day
• Volume replacement with isotonic saline (10-20 mL/kg) for circulatory collapse

Monitoring Requirements

Clinical: Blood pressure, heart rate, glycemia, urine output, weight, alertness 1

Biochemical: Electrolytes, sodium correction rate (must not exceed 1 mEq/kg/hr) 1

Important Caveats and Pitfalls

Controversy in Relative Adrenal Insufficiency

The 2020 Surviving Sepsis Campaign guidelines reflect ongoing uncertainty: "We suggest against using intravenous hydrocortisone if adequate fluid resuscitation and vasopressor therapy restore hemodynamic stability" (weak recommendation) 4. However, "either hydrocortisone or no hydrocortisone may be used if vasopressors fail to restore stability" (weak recommendation) 4.

This contrasts with the stronger 2013 recommendation for timely therapy in absolute adrenal insufficiency 3. The key distinction: proven or suspected absolute adrenal insufficiency warrants treatment, while relative insufficiency remains debated.

Age-Related Considerations

• Children are more likely than adults to have absolute adrenal insufficiency 2
• Adrenal insufficiency incidence increases significantly in children >2 years 5
• Neonates may require higher initial replacement doses (20-40 mg/m²/day) 1

Practical Challenges

• Do not delay treatment waiting for cortisol/ACTH results if adrenal crisis suspected 1
• Draw blood samples for cortisol/ACTH before administering hydrocortisone when possible 1
• Clinical improvement after hydrocortisone is the best diagnostic criterion 1
• Empiric corticosteroid use by clinicians before formal assessment remains a significant barrier to protocol adherence 6

Mineralocorticoid Considerations

• Fludrocortisone not needed during acute crisis when hydrocortisone dose >50 mg/day (provides sufficient mineralocorticoid activity) 1
• Resume fludrocortisone only when hydrocortisone tapered to <50 mg/day in primary adrenal insufficiency 1

Evidence Limitations

Recent pediatric trials show hydrocortisone reduces vasopressor requirements but has not demonstrated mortality benefit 6, 7, 5. The 2017 randomized trial showed significantly shorter shock reversal time with early steroids (p=0.046) without increased mortality or superinfection 7. However, definitive large-scale pediatric trials are still needed 2, 8.